6505--Request for Information (RFI) - Specialty Pharmacy List - Pharmaceutical Prime Vendor (PPV) 2028

AMENDMENT 0001 Request for Information (RFI) 36E79727Q0001 Specialty Pharmacy - Pharmaceutical Prime Vendor (PPV) 2028 Purpose of Amendment: This amendment provides a list of Specialty Products on FSS Not Distributed Through PPV.

Attachment: Attachment 1 Specialty Products on FSS Not Distributed Through PPV The attached list identifies specialty pharmaceutical products currently on the Federal Supply Schedule (FSS) that are not presently distributed through the Pharmaceutical Prime Vendor (PPV) program. The list is provided for reference purposes only and may include products that are subject to specialty, limited, closed, or other restricted distribution models. Inclusion on this list should not be interpreted as confirmation that a product is a Limited Distribution Drug (LDD) or Closed Distribution Product (CDP). Distribution arrangements, manufacturer requirements, and product availability may change over time; therefore, this list is not intended to be exhaustive and should be considered a point-in-time reference only.

Response Date: Unchanged. Responses are due no later than 11:00 AM Central Time, November 16, 2026, via email to [email protected]. All other information in the RFI remains unchanged.